ASCO 2013: Dr. Burtness on Induction Chemo, Cetuximab + IMRT for HPV-Associated SCC

Share it with your friends Like

Thanks! Share it with your friends!


Barbara Burtness, MD, Fox Chase Cancer Center, discusses results of EKOG E 130 on induction chemo followed by cetuximab with low-dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx.


Write a comment